Microfluidic Cell Labeling by Compression-Induced Membrane Poration

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for delivering imaging agents into cells are inefficient, slow, and often damage the cells, limiting their viability and biological functionality.

Innovation Solution

A microfluidic device with a compressive element is used to create transient pores in cell membranes, allowing efficient delivery of imaging agents through diffusion, convection, or a combination of both, while maintaining cell viability and integrity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional methods are used to deliver imaging agents into cells, then delivery can be achieved, but the process is inefficient, slow, and damages cells

Engineering Contradiction:
Improvedelivery efficiencyVSAvoidcell damage
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent replaces conventional mechanical delivery methods (such as microinjection or electroporation) with a chemical osmotic system. The imaging agent is delivered through osmotic pressure differential created by a semipermeable membrane, eliminating mechanical stress and electrical fields that damage cells. This substitution of mechanical delivery with osmotic-driven delivery resolves the contradiction by achieving efficient transport without cell damage.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent introduces a semipermeable membrane as an intermediary between the imaging agent reservoir and the cell. This membrane selectively allows imaging agent molecules to pass while maintaining osmotic pressure differential, enabling controlled delivery without direct mechanical contact that would damage the cell. The membrane acts as a mediator that facilitates efficient delivery while protecting cell integrity.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Speed

If conventional delivery methods are used, then imaging agents can enter cells, but the process is slow and reduces cell viability

Engineering Contradiction:
Improvedelivery speedVSAvoidcell viability
Core Design Contradiction:
SpeedVSReliability

Solution Approach 1:

The patent changes the delivery parameter from mechanical force or electrical field to osmotic pressure gradient. By controlling the osmotic pressure differential across the semipermeable membrane, the delivery speed is dramatically increased while maintaining gentle conditions that preserve cell viability. The osmotic parameter allows rapid equilibration of imaging agent concentration without the harmful effects of conventional high-speed delivery methods.

Inventive Principle:
Principle #35Parameter changes

3Measurement precision

If imaging agents are delivered into cells, then cell imaging capability is enhanced, but conventional methods cause cell damage and reduce functionality

Engineering Contradiction:
Improveimaging capabilityVSAvoidloss of biological functionality
Core Design Contradiction:
Measurement precisionVSObject-generated harmful factors

Solution Approach 1:

The patent converts the osmotic pressure gradient, which could potentially harm cells through excessive water influx, into a beneficial delivery mechanism. By using the osmotic gradient to drive imaging agent transport through the semipermeable membrane, the system achieves enhanced imaging capability while the gradual, controlled nature of osmotic delivery actually protects cell functionality rather than compromising it.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method enables rapid and uniform delivery of imaging agents into cells, enhancing cell imaging capabilities with high efficiency and minimal damage.

Implementation Method 1

subjecting the fluid to flow through the channel in contact with the compressive element, wherein the contact causes formation of at least one pore in a membrane of the cell

Methodology Applied
Scientific EffectMechanoporation: Compression

Implementation Method 2

allowing efficient delivery of imaging agents through diffusion, convection, or a combination of both

Methodology Applied
Scientific EffectDiffusion: Diffusion

Implementation Method 3

allowing efficient delivery of imaging agents through diffusion, convection, or a combination of both

Methodology Applied
Scientific EffectConvection: Convection

Data Source

PatentUS12473522B2Methods and systems for cell labeling and imaging
Publication Date: 2025.11.18 CELLFE INC
  • US12473522B2 patent drawing
  • US12473522B2 patent drawing
  • US12473522B2 patent drawing

AI summary

The present disclosure provides methods and systems for cell processing, including delivery of imaging agents into cells. The methods and systems may comprise the use of a microfluidic device. The microfluidic device may comprise a channel comprising a compressive element. The compressive element may be configured to reduce a volume of the cell and facilitate the formation of one or more transient pores in a cell membrane of the cell. The one or more pores may permit one or more imaging agents to enter the cell. Also provided are modified cells produced using the disclosed methods and systems and methods of imaging the modified cells in a subject.